- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Interventional Cardiology market will register a 3.1% CAGR in terms of revenue, the global market size will reach $ 3 million by 2025, from $ 3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional Cardiology business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Cardiology market by type, application, key manufacturers and key regions and countries.
This study considers the Interventional Cardiology value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cardiology catheters
Guidewires
Balloon catheters
Coronary stents
Fractional flow reserve
Intravascular ultrasound
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic, Inc.
Cordis Cashel
Boston Scientific Corporation
MINVASYS S.A.S.
BIOTRONIK SE & Co. KG
Abbott Vascular
KANEKA
Bard Peripheral Vascular，Inc
OrbusNeich Medical, BV
TERUMO CORPORATION
Kimal Plc
Lepu
Siemens Medical Solutions USA, Inc
MicroPort
Volcano Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interventional Cardiology consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Interventional Cardiology market by identifying its various subsegments.
Focuses on the key global Interventional Cardiology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interventional Cardiology with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interventional Cardiology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Cardiology Consumption 2015-2025
2.1.2 Interventional Cardiology Consumption CAGR by Region
2.2 Interventional Cardiology Segment by Type
2.2.1 Cardiology catheters
2.2.2 Guidewires
2.2.3 Balloon catheters
2.2.4 Coronary stents
2.2.5 Fractional flow reserve
2.2.6 Intravascular ultrasound
2.3 Interventional Cardiology Consumption by Type
2.3.1 Global Interventional Cardiology Consumption Market Share by Type (2015-2020)
2.3.2 Global Interventional Cardiology Revenue and Market Share by Type (2015-2020)
2.3.3 Global Interventional Cardiology Sale Price by Type (2015-2020)
2.4 Interventional Cardiology Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Interventional Cardiology Consumption by Application
2.5.1 Global Interventional Cardiology Consumption Market Share by Type (2015-2020)
2.5.2 Global Interventional Cardiology Value and Market Share by Type (2015-2020)
2.5.3 Global Interventional Cardiology Sale Price by Type (2015-2020)
3 Global Interventional Cardiology by Company
3.1 Global Interventional Cardiology Sales Market Share by Company
3.1.1 Global Interventional Cardiology Sales by Company (2018-2020)
3.1.2 Global Interventional Cardiology Sales Market Share by Company (2018-2020)
3.2 Global Interventional Cardiology Revenue Market Share by Company
3.2.1 Global Interventional Cardiology Revenue by Company (2018-2020)
3.2.2 Global Interventional Cardiology Revenue Market Share by Company (2018-2020)
3.3 Global Interventional Cardiology Sale Price by Company
3.4 Global Interventional Cardiology Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Interventional Cardiology Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Interventional Cardiology Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Interventional Cardiology by Regions
4.1 Interventional Cardiology by Regions
4.2 Americas Interventional Cardiology Consumption Growth
4.3 APAC Interventional Cardiology Consumption Growth
4.4 Europe Interventional Cardiology Consumption Growth
4.5 Middle East & Africa Interventional Cardiology Consumption Growth
5 Americas
5.1 Americas Interventional Cardiology Consumption by Countries
5.1.1 Americas Interventional Cardiology Consumption by Countries (2015-2020)
5.1.2 Americas Interventional Cardiology Value by Countries (2015-2020)
5.2 Americas Interventional Cardiology Consumption by Type
5.3 Americas Interventional Cardiology Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Interventional Cardiology Consumption by Regions
6.1.1 APAC Interventional Cardiology Consumption by Regions (2015-2020)
6.1.2 APAC Interventional Cardiology Value by Regions (2015-2020)
6.2 APAC Interventional Cardiology Consumption by Type
6.3 APAC Interventional Cardiology Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Interventional Cardiology by Countries
7.1.1 Europe Interventional Cardiology Consumption by Countries (2015-2020)
7.1.2 Europe Interventional Cardiology Value by Countries (2015-2020)
7.2 Europe Interventional Cardiology Consumption by Type
7.3 Europe Interventional Cardiology Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Interventional Cardiology by Countries
8.1.1 Middle East & Africa Interventional Cardiology Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Interventional Cardiology Value by Countries (2015-2020)
8.2 Middle East & Africa Interventional Cardiology Consumption by Type
8.3 Middle East & Africa Interventional Cardiology Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Interventional Cardiology Distributors
10.3 Interventional Cardiology Customer
11 Global Interventional Cardiology Market Forecast
11.1 Global Interventional Cardiology Consumption Forecast (2021-2025)
11.2 Global Interventional Cardiology Forecast by Regions
11.2.1 Global Interventional Cardiology Forecast by Regions (2021-2025)
11.2.2 Global Interventional Cardiology Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Interventional Cardiology Forecast by Type
11.8 Global Interventional Cardiology Forecast by Application
12 Key Players Analysis
12.1 Medtronic, Inc.
12.1.1 Company Information
12.1.2 Interventional Cardiology Product Offered
12.1.3 Medtronic, Inc. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic, Inc. Latest Developments
12.2 Cordis Cashel
12.2.1 Company Information
12.2.2 Interventional Cardiology Product Offered
12.2.3 Cordis Cashel Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Cordis Cashel Latest Developments
12.3 Boston Scientific Corporation
12.3.1 Company Information
12.3.2 Interventional Cardiology Product Offered
12.3.3 Boston Scientific Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boston Scientific Corporation Latest Developments
12.4 MINVASYS S.A.S.
12.4.1 Company Information
12.4.2 Interventional Cardiology Product Offered
12.4.3 MINVASYS S.A.S. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 MINVASYS S.A.S. Latest Developments
12.5 BIOTRONIK SE & Co. KG
12.5.1 Company Information
12.5.2 Interventional Cardiology Product Offered
12.5.3 BIOTRONIK SE & Co. KG Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 BIOTRONIK SE & Co. KG Latest Developments
12.6 Abbott Vascular
12.6.1 Company Information
12.6.2 Interventional Cardiology Product Offered
12.6.3 Abbott Vascular Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Abbott Vascular Latest Developments
12.7 KANEKA
12.7.1 Company Information
12.7.2 Interventional Cardiology Product Offered
12.7.3 KANEKA Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 KANEKA Latest Developments
12.8 Bard Peripheral Vascular，Inc
12.8.1 Company Information
12.8.2 Interventional Cardiology Product Offered
12.8.3 Bard Peripheral Vascular，Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Bard Peripheral Vascular，Inc Latest Developments
12.9 OrbusNeich Medical, BV
12.9.1 Company Information
12.9.2 Interventional Cardiology Product Offered
12.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 OrbusNeich Medical, BV Latest Developments
12.10 TERUMO CORPORATION
12.10.1 Company Information
12.10.2 Interventional Cardiology Product Offered
12.10.3 TERUMO CORPORATION Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 TERUMO CORPORATION Latest Developments
12.11 Kimal Plc
12.11.1 Company Information
12.11.2 Interventional Cardiology Product Offered
12.11.3 Kimal Plc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Kimal Plc Latest Developments
12.12 Lepu
12.12.1 Company Information
12.12.2 Interventional Cardiology Product Offered
12.12.3 Lepu Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Lepu Latest Developments
12.13 Siemens Medical Solutions USA, Inc
12.13.1 Company Information
12.13.2 Interventional Cardiology Product Offered
12.13.3 Siemens Medical Solutions USA, Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Siemens Medical Solutions USA, Inc Latest Developments
12.14 MicroPort
12.14.1 Company Information
12.14.2 Interventional Cardiology Product Offered
12.14.3 MicroPort Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 MicroPort Latest Developments
12.15 Volcano Corporation
12.15.1 Company Information
12.15.2 Interventional Cardiology Product Offered
12.15.3 Volcano Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Volcano Corporation Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Interventional Cardiology Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Play
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
